Amgen Ends Non-U.S. Co-Marketing Pact With GSK

11.04.2014 - U.S. biotechnology firm Amgen, the world's largest, is ending its agreement with the U.K. drugmaker GlaxoSmithkline for the marketing of its osteoporosis drug in some regions...